Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warm vs Conventional Lignocaine for IANB in Mandibular Molars
NCT06806202Phase 2Recruiting
- Sponsor
- Armed Forces Institute of Dentistry
- Start
- Dec 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of lidocaine in irreversible pulpitis (2 arms), sponsored by Armed Forces Institute of Dentistry. Primary endpoints: Pain during administration of injection and Onset of anesthesia in seconds up to 15 minutes. Started Dec 2024; status: recruiting.
02
Drugs
lidocaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06806202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06806202.